Below you will find example sentences with "boston scientific". The examples show how this phrase is used in natural context and which words often surround it.
Boston Scientific in a sentence
Corpus data
- Displayed example sentences: 20
- Discovered as a combination around: scientific
- Corpus frequency in the collocation scan: 9
- Phrase length: 2 words
- Average sentence length: 21.6 words
Sentence profile
- Phrase position: 5 start, 14 middle, 1 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis
- The phrase "boston scientific" has 2 words and usually appears in the middle in these examples. The average sentence has 21.6 words and is mostly made up of statements.
- Around this phrase, patterns and context words such as and allow boston scientific to maintain, boston scientific co has, quarter, llc and analysts stand out.
- In the phrase index, this combination connects with boston bruins, boston red, boston cbs, scientific research, fisher scientific and scientific community, linking the page to nearby combinations.
Example types with boston scientific
This selection groups the examples by length and sentence type, making usage of the full phrase easier to scan:
Boston Scientific stock opened at $52.12 on Thursday. (9 words)
Brookstone Capital Management Lowers Stock Position in Boston Scientific Co. (10 words)
FourThought Financial LLC boosted its holdings in Boston Scientific by 40.6% in the third quarter. (16 words)
Similarly, Boston Scientific has invested €30m in its Cork facility to accelerate the development and manufacturing of minimally-invasive medical technologies, and is expected to generate over 70 engineering and production jobs over the next three years. (37 words)
Other notable events of interest include Myriad Genetics' () Investor Day, Boston Scientific's () Investor Day, Driven Brands' () Investor Day, Avient's () Sustainability Day, Procore's () Investor Day, and Exxon Mobil's () Product Solutions Spotlight. (34 words)
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat. (33 words)
Example sentences (20)
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.
AbbVie Inc., Alma Lasers GmbH, AngioDynamics Inc., Bausch Health Co Inc., Boston Scientific Corp., Candela Corp, Cutera Inc., Cynosure LLC, El.
BerganKDV Wealth Management LLC increased its holdings in shares of Boston Scientific Co. () by 44.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Boston Scientific Co. has a twelve month low of $44.35 and a twelve month high of $56.90.
Boston Scientific stock opened at $52.12 on Thursday.
Brookstone Capital Management Lowers Stock Position in Boston Scientific Co.
Cibc World Markets Corp’s holdings in Boston Scientific were worth $841,000 at the end of the most recent quarter.
Equities research analysts expect that Boston Scientific will post 1.93 earnings per share for the current year.
Finally, Nuveen Asset Management LLC boosted its position in shares of Boston Scientific by 10.9% during the 3rd quarter.
FourThought Financial LLC boosted its holdings in Boston Scientific by 40.6% in the third quarter.
Harbor Investment Advisory LLC lifted its holdings in shares of Boston Scientific by 5.5% during the third quarter.
Hazlett Burt & Watson Inc. boosted its stake in shares of Boston Scientific by 56.7% during the 4th quarter.
Householder Group Estate & Retirement Specialist LLC bought a new stake in Boston Scientific in the 1st quarter valued at $26,000.
On average, analysts forecast that Boston Scientific will post 1.9 earnings per share for the current year.
On average, equities research analysts forecast that Boston Scientific Co. will post 1.95 EPS for the current fiscal year.
Other notable events of interest include Myriad Genetics' () Investor Day, Boston Scientific's () Investor Day, Driven Brands' () Investor Day, Avient's () Sustainability Day, Procore's () Investor Day, and Exxon Mobil's () Product Solutions Spotlight.
Research analysts predict that Boston Scientific Co. will post 2.01 earnings per share for the current year.
Sales are well-diversified across medical specialties and allow Boston Scientific to maintain a strong market footing.
Similarly, Boston Scientific has invested €30m in its Cork facility to accelerate the development and manufacturing of minimally-invasive medical technologies, and is expected to generate over 70 engineering and production jobs over the next three years.
Argus lifted their price target on shares of Boston Scientific from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday.